Is BVXV or DIVO a better dividend investment in 2026?

BVXV currently yields 147.06% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: BVXV offers higher current income.

What is the dividend yield difference between BVXV and DIVO?

BVXV has a forward dividend yield of 147.06% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 140.57 percentage points.

Home › Compare › BVXV vs DIVO

BVXV vs DIVO: Dividend Comparison 2026

BVXV yields 147.06% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BVXV wins by $22.57M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BVXV

● Live price

147.06%

Share price

$1.36

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.60M

Annual income

$9,667,205.19

Full BVXV calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — BVXV vs DIVO

📍 BVXV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BVXV	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BVXV + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BVXV pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVXV

Annual income on $10K today (after 15% tax)

$12,500.00/yr

After 10yr DRIP, annual income (after tax)

$8,217,124.41/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, BVXV beats the other by $8,216,289.98/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVXV + DIVO for your $10,000?

BVXV: 50%DIVO: 50%

100% DIVO50/50100% BVXV

Portfolio after 10yr

$11.31M

Annual income

$4,834,093.43/yr

Blended yield

42.72%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVXV buys

DIVO buys

No recent congressional trades found for BVXV or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBVXVDIVO

Forward yield	147.06% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$22.60M	$30.7K ✓
Annual income after 10y	$9,667,205.19 ✓	$981.68
Total dividends collected	$20.88M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BVXV vs DIVO ($10,000, DRIP)

Year	BVXV Portfolio	BVXV Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$25,406	$14,705.88	$11,349	$649.42	+$14.1K → BVXV
2	$62,102	$34,917.38	$12,833	$688.83	+$49.3K → BVXV
3	$146,216	$79,767.65	$14,459	$727.90	+$131.8K → BVXV
4	$331,975	$175,523.78	$16,238	$766.49	+$315.7K → BVXV
5	$727,658	$372,444.73	$18,179	$804.47	+$709.5K → BVXV
6	$1,541,551	$762,956.42	$20,293	$841.71	+$1.52M → BVXV
7	$3,160,048	$1,510,588.88	$22,591	$878.14	+$3.14M → BVXV
8	$6,275,251	$2,893,998.93	$25,087	$913.65	+$6.25M → BVXV
9	$12,085,478	$5,370,960.29	$27,791	$948.18	+$12.06M → BVXV
10	$22,598,667	$9,667,205.19	$30,718	$981.68	+$22.57M → BVXV

BVXV vs DIVO: Complete Analysis 2026

BVXV — Stock

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Full BVXV Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this BVXV vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVXV vs SCHD BVXV vs JEPI BVXV vs O BVXV vs KO BVXV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.